Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Octavio Ramilo

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
The New England Journal of Medicine|September 17, 2025
Clesrovimab for Prevention of RSV Disease in Healthy InfantsHeather J Zar, Eric A F Simões, Shabir A Madhi, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 24, 2024
Longitudinal transcriptional immune profiles and persistent wheezing in moderate-to-late preterm infantsRosa Rodriguez-Fernandez, Zhaohui Xu, Antonio Moreno-Galdó, et al.
Nature Immunology|August 5, 2020
Mapping systemic lupus erythematosus heterogeneity at the single-cell levelDjamel Nehar-Belaid, Seunghee Hong, Radu Marches, et al.
The Journal of Experimental Medicine|May 25, 2016
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid feverChristoph J Blohmke, Thomas C Darton, Claire Jones, et al.
Nature Communications|July 20, 2021
Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome dataMatthew C Altman, Darawan Rinchai, Nicole Baldwin, et al.
The Lancet. Infectious Diseases|June 20, 2018
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidatesNatalie I Mazur, Deborah Higgins, Marta C Nunes, et al.
Expert Review of Anti-Infective Therapy|March 20, 2025
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in childrenXavier Carbonell-Estrany, Eric A F Simões, Louis Bont, et al.
Nature|March 12, 2026
B cell imprinting in children impairs antibodies to the haemagglutinin stalkJiayi Sun, Gyunghee Jo, Chloe A Troxell, et al.
The Lancet. Infectious Diseases|August 11, 2022
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscapeNatalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
JAMA Pediatrics|February 19, 2019
A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial InfectionsNathan Kuppermann, Peter S Dayan, Deborah A Levine, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
The New England Journal of Medicine|September 17, 2025
Clesrovimab for Prevention of RSV Disease in Healthy InfantsHeather J Zar, Eric A F Simões, Shabir A Madhi, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 24, 2024
Longitudinal transcriptional immune profiles and persistent wheezing in moderate-to-late preterm infantsRosa Rodriguez-Fernandez, Zhaohui Xu, Antonio Moreno-Galdó, et al.
Nature Immunology|August 5, 2020
Mapping systemic lupus erythematosus heterogeneity at the single-cell levelDjamel Nehar-Belaid, Seunghee Hong, Radu Marches, et al.
The Journal of Experimental Medicine|May 25, 2016
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid feverChristoph J Blohmke, Thomas C Darton, Claire Jones, et al.
Nature Communications|July 20, 2021
Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome dataMatthew C Altman, Darawan Rinchai, Nicole Baldwin, et al.
The Lancet. Infectious Diseases|June 20, 2018
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidatesNatalie I Mazur, Deborah Higgins, Marta C Nunes, et al.
Expert Review of Anti-Infective Therapy|March 20, 2025
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in childrenXavier Carbonell-Estrany, Eric A F Simões, Louis Bont, et al.
Nature|March 12, 2026
B cell imprinting in children impairs antibodies to the haemagglutinin stalkJiayi Sun, Gyunghee Jo, Chloe A Troxell, et al.
The Lancet. Infectious Diseases|August 11, 2022
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscapeNatalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
JAMA Pediatrics|February 19, 2019
A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial InfectionsNathan Kuppermann, Peter S Dayan, Deborah A Levine, et al.
Pageof 26